NR1I2 and non-small cell lung carcinoma: Kong et al. found that, among non-small cell lung cancer cases (n = 37) compared to controls (n = 17), NR1I2 (aka PXR) expression was significantly higher among non-small cell lung cancer tumors compared to peripheral blood mononuclear cells [47].